Explore News By Topic


Breaking News: PCF Prostate Cancer Screening Guidelines for Black Men in the U.S.

Black men in the United States are more likely to be diagnosed with and to die from prostate cancer vs. men of other backgrounds. They are diagnosed at a younger age and with more advanced disease. Yet, Black men remained a footnote in national prostate cancer screening guidelines. These stark,... Read More


Prostate cancer cases expected to double worldwide between 2020 and 2040, new analysis suggests

Annual prostate cancer cases are projected to rise from 1.4 million in 2020 to 2.9 million in 2040, and annual deaths to increase by 85% to almost 700,000 over the same timeframe, mainly among men in low-and middle-income countries (LMICs). The Lancet Commission on prostate cancer argues that the ‘informed... Read More


2024 AACR-Prostate Cancer Foundation Scholar-in-Training Award Recipients

The Prostate Cancer Foundation Scholar-in-Training Awards recognize promising young cancer researchers presenting outstanding proffered papers relating to advanced prostate cancer at the American Association for Cancer Research (AACR) Annual Meeting. The Prostate Cancer Foundation is one of 13 organizations sponsoring this highly competitive awards program in conjunction with the AACR.... Read More


Atlanta Hawks Foundation and Ressler Gertz Family Foundation Team Up To Donate $150,000 to Prostate Cancer Foundation

**To download photos and video from the PCF check presentation, click here.**   FOR IMMEDIATE RELEASE: 3/23/24 CONTACT: Max Strauss, Atlanta Hawks Brand Communications, [email protected]   ATLANTA HAWKS FOUNDATION AND RESSLER GERTZ FAMILY FOUNDATION TEAM UP TO DONATE $150,000 TO PROSTATE CANCER FOUNDATION Nearly a Million Dollars Raised Since 2019... Read More


The Prostate Cancer Foundation Announces 2023 Challenge Awards Totaling More Than $21 Million For Prostate Cancer Research

LOS ANGELES, Calif., March 14, 2024 – The Prostate Cancer Foundation (PCF) today announced the 2023 Class of PCF Team Challenge Award recipients and a total of more than $21 million in funding for innovative prostate cancer research. PCF Challenge Awards fund international, multi-institutional, cross-disciplinary teams of investigators conducting highly... Read More


UroToday and PRIMR Announce Strategic Partnership to Enhance Clinical Trial Awareness

Digital Science Press / UroToday RENO, Nev., March 5, 2024 /PRNewswire/ -- UroToday, the premier global hub for urology news and education, and PRIMR, a pioneering oncology clinical trial patient education company, proudly announce their inaugural strategic partnership. This groundbreaking collaboration is set to redefine clinical trial awareness and education, marking a... Read More


The Prostate Cancer Foundation and the American Cancer Society Announce First ACS-PCF Young Investigator Award

LOS ANGELES, Calif., February 22, 2024 – The Prostate Cancer Foundation (PCF) and the American Cancer Society (ACS) today announced the ACS-PCF Young Investigator Award totaling $225,000 over three years to support a novel health equity research project that aims to reduce disparities in access to modern prostate cancer care... Read More


New Prostate Cancer Foundation-Funded Research To Speed Up Prostate Cancer Clinical Trials Worldwide

LOS ANGELES, Calif., January 11, 2024 -- New analysis of data published by Susan Halabi, PhD, of Duke University, USA could facilitate approval of new prostate cancer treatments almost two years earlier than the current standard. The study published online January 5, 2024, in the Journal of Clinical Oncology, reviewed... Read More


The Prostate Cancer Foundation and Bayer Announce First Ever Bayer-PCF Health Equity Research Challenge Awards

LOS ANGELES, Calif., November 30, 2023 – The Prostate Cancer Foundation (PCF) and Bayer today announced three 2023 Bayer-PCF Health Equity Research Challenge Awards totaling $600,000. The awards will support novel health equity research projects with the goal of reducing racial and ethnic disparities in the diagnosis and treatment of... Read More


Breaking News: FDA Approves Enzalutamide as a Treatment Option for Patients with Recurrent Prostate Cancer at High Risk of Metastases

Patients who have been treated for localized prostate cancer and are now seeing their PSA rise rapidly are at high risk of metastasis and of death from prostate cancer. Now, patients and their doctors have a new treatment option that decreases these risks. The FDA has approved enzalutamide alone OR... Read More